ACUTA CAPITAL PARTNERS, LLC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 283 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is 0.89 and the average weighting 0.3%.

Quarter-by-quarter ownership
ACUTA CAPITAL PARTNERS, LLC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2023$980,650
-41.1%
27,500
-33.0%
0.66%
-35.2%
Q4 2022$1,664,136
-42.5%
41,029
-53.1%
1.02%
-17.8%
Q3 2022$2,892,000
+32.7%
87,500
+41.3%
1.24%
+2.6%
Q2 2022$2,180,000
-42.5%
61,926
-24.9%
1.21%
-31.5%
Q1 2022$3,794,000
-45.8%
82,500
-21.8%
1.77%
-39.7%
Q4 2021$6,995,000
-7.8%
105,500
-13.2%
2.94%
+9.9%
Q3 2021$7,585,000
-15.2%
121,500
+12.5%
2.68%
-25.1%
Q2 2021$8,945,000
+24.9%
108,0000.0%3.58%
+38.5%
Q1 2021$7,161,000
-32.9%
108,000
-22.3%
2.58%
-11.0%
Q4 2020$10,665,000
+144.0%
139,000
+36.9%
2.90%
+144.5%
Q3 2020$4,371,000
+68.7%
101,500
+69.2%
1.19%
+58.5%
Q2 2020$2,591,000
-17.9%
60,000
-45.3%
0.75%
-51.0%
Q1 2020$3,156,000
-88.8%
109,700
-75.2%
1.53%
-78.0%
Q4 2019$28,068,000
+157.0%
442,500
+14.2%
6.95%
-11.8%
Q3 2019$10,920,000
-13.9%
387,500
-19.0%
7.88%
+74.8%
Q2 2019$12,680,000
+312.5%
478,500
+185.7%
4.51%
+208.4%
Q1 2019$3,074,000
-83.6%
167,500
-82.8%
1.46%
-78.1%
Q3 2018$18,691,000
+11.7%
975,000
-20.8%
6.67%
+123.9%
Q2 2018$16,732,000
+31.7%
1,230,330
-30.2%
2.98%
+43.5%
Q1 2018$12,706,0001,762,2062.08%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q4 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 908,474$24,410,69622.12%
Western Financial Corp/CA 820,239$22,039,82216.16%
JOHNSON & JOHNSON 247,598$6,652,9582.45%
WEALTH EFFECTS LLC 164,750$4,426,8352.19%
M28 Capital Management LP 67,400$1,811,0382.08%
Privium Fund Management B.V. 259,036$6,960,2982.07%
Evolutionary Tree Capital Management, LLC 51,266$1,377,5171.78%
Avidity Partners Management LP 1,063,897$28,586,9121.15%
SECTORAL ASSET MANAGEMENT INC 157,552$4,233,4220.82%
Vivo Capital, LLC 137,411$3,692,2340.40%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders